NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
82381-2174-1 | 82381-2174 | HUMAN PRESCRIPTION DRUG | BRENZAVVY | Bexagliflozin | TABLET | ORAL | 20230713 | N/A | NDA | NDA214373 | TheracosBio, LLC | BEXAGLIFLOZIN | 20 mg/1 | 30 TABLET in 1 BOTTLE (82381-2174-1) |
82381-2174-2 | 82381-2174 | HUMAN PRESCRIPTION DRUG | BRENZAVVY | Bexagliflozin | TABLET | ORAL | 20230713 | N/A | NDA | NDA214373 | TheracosBio, LLC | BEXAGLIFLOZIN | 20 mg/1 | 90 TABLET in 1 BOTTLE (82381-2174-2) |
82381-2000-9 | 82381-2000 | HUMAN PRESCRIPTION DRUG | Bexagliflozin | Bexagliflozin | TABLET | ORAL | 20240319 | N/A | NDA AUTHORIZED GENERIC | NDA214373 | TheracosBio, LLC | BEXAGLIFLOZIN | 20 mg/1 | 90 TABLET in 1 BOTTLE (82381-2000-9) |
82381-2000-8 | 82381-2000 | HUMAN PRESCRIPTION DRUG | Bexagliflozin | Bexagliflozin | TABLET | ORAL | 20240319 | N/A | NDA AUTHORIZED GENERIC | NDA214373 | TheracosBio, LLC | BEXAGLIFLOZIN | 20 mg/1 | 30 TABLET in 1 BOTTLE (82381-2000-8) |